About Trip
Trip Conant is a Managing Director at Tully & Holland, where he works with consumer and healthcare companies on strategic growth and value creation.
Trip brings over a decade of experience in private equity, investment banking, and corporate development, with a proven track record of advising and investing in consumer and healthcare companies. Most recently, he was with Webster Equity Partners, a healthcare and consumer-focused private equity firm, where he led investments in the Pharma Services sector and served as the team lead on several portfolio companies.
Trip has also held roles in Corporate Development at Thermo Fisher Scientific and in growth equity investing at Winona Capital. He started his career in investment banking at William Blair in Chicago. Throughout these roles, he has executed numerous M&A transactions, built deep sector expertise, and helped businesses unlock value through strategic growth initiatives.
Trip earned his MBA from Babson College’s F.W. Olin Graduate School of Business, where he graduated magna cum laude, and was inducted into the Beta Gamma Sigma Honor Society. While at Babson, he held leadership roles in the Entrepreneurship Through Acquisition Club and co-founded SMILI, an AI-powered platform for children's mental health. Trip is also a graduate of Cornell University and was a member of the Varsity Heavyweight Rowing team, where he won a National Championship and broke the course record.
Outside of work, Trip enjoys gardening, mixology, golfing, cooking, biking, and spending time with his mini–Australian Shepherd and young son.
Articles & Insights

Snack Food Industry Update October 2026
US snack sales grew about 4.8% to roughly $156 billion, and almost none of it came from volume. The companies winning no...
Read →
Women's Health Industry Update October 2026
A category that lived in three different aisles is becoming a destination, and strategic acquirers have moved with it. D...
Read →
Beverage Industry Update Q2 2026
The strategics have stopped waiting for internal innovation to catch the growth brands. From PepsiCo's $1.95 billion pur...
Read →
Biotech Update Q2 2026
Biotech capital invested more than doubled quarter over quarter to $133.2 billion, biopharma M&A ran at $55.1 billion in...
Read →
Consumer Industry Update Q2 2026
Consumer median deal values set a twelve-quarter record and healthcare multiples touched a twenty-year high, while spons...
Read →
Consumer Industry Update Q1 2026
Global deal value set an all-time record while capital crowded into a handful of megadeals, and healthcare capital inves...
Read →
Pet Industry Update January 2026
Revenue has grown more than 70% since 2018, and buyers are paying up for the businesses built on recurring care. Our 202...
Read →
Consumer Industry Update Q4 2025
Global M&A closed 2025 at nearly $5 trillion, the strongest year for dealmaking on record, and the fourth quarter set a ...
Read →